PHIO PHARMACEUTICALS CORP. Repayments of Long-term Capital Lease Obligations
PHIO PHARMACEUTICALS CORP. (PHIO) reported Repayments of Long-term Capital Lease Obligations of $5.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermCapitalLeaseObligations · last filed 2015-03-30
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for the quarter ending 2013-06-30 was $2.00K, a 71.43% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for the quarter ending 2013-03-31 was $3.00K, a 75.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for fiscal 2013 was $5.00K, a 82.76% decline from fiscal 2012.
- PHIO PHARMACEUTICALS CORP. repayments of long-term capital lease obligations for fiscal 2012 was $29.00K.
| Period end | Repayments of Long-term Capital Lease Obligations 3 month | Repayments of Long-term Capital Lease Obligations 6 month | Repayments of Long-term Capital Lease Obligations 9 month | Repayments of Long-term Capital Lease Obligations 12 month | Repayments of Long-term Capital Lease Obligations 111 month | Repayments of Long-term Capital Lease Obligations 114 month | Repayments of Long-term Capital Lease Obligations 117 month |
|---|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $0.00 derived: sum of 2 quarters · filed 2015-03-30 | $2.00K derived: sum of 3 quarters · filed 2015-03-30 | $5.00K 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $2.00K derived: sum of 2 quarters · filed 2014-11-13 | $5.00K 10-Q · filed 2014-11-13 | $8.00K derived: sum of 4 quarters · filed 2014-11-13 | |||
| 2013-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $5.00K 10-Q · filed 2014-08-14 | $8.00K derived: sum of 3 quarters · filed 2014-08-14 | $15.00K derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | $3.00K 10-Q · filed 2014-05-14 | $6.00K derived: sum of 2 quarters · filed 2014-05-14 | $13.00K derived: sum of 3 quarters · filed 2014-05-14 | $20.00K derived: sum of 4 quarters · filed 2014-05-14 | |||
| 2012-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $10.00K derived: sum of 2 quarters · filed 2014-03-28 | $17.00K derived: sum of 3 quarters · filed 2014-03-28 | $29.00K 10-K · filed 2014-03-28 | |||
| 2012-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $14.00K derived: sum of 2 quarters · filed 2013-11-14 | $26.00K 10-Q · filed 2013-11-14 | $269.00K 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $19.00K 10-Q · filed 2013-08-14 | $263.00K 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | $12.00K 10-Q · filed 2013-05-15 | $255.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |